Greenspan Is Serious–Are You?
Stocks were broadly lower this
options expiration Friday on a spike in
oil and a weak dollar triggered by Greenspan’s comments. Greenspan said
that eventually foreign investors will stop financing the US current account
deficit, and that rates would have to rise.
Note the possible head and shoulders pattern in
bonds:

It was the weakest performance in a month–with
the Dow down triple digits–as interest rate sensitive stocks were hit hard, as
were technology stocks. For the week, Nasdaq winners were Hardware, +2% and
Semis, +2.5%; losers were Biotech, -4% and Internet, -4%.
Disney (DIS)
beat by a penny; profits rose 24%; revenue was $7.54 billion, up 8% from a
year ago. CFO Tom Staggs said the company expects double-digit growth for the
next few years.
Drug stocks were in focus after a US health
official said drugs manufactured by Pfizer
(
PFE |
Quote |
Chart |
News |
PowerRating) (Bextra) and Abbott
(
ABT |
Quote |
Chart |
News |
PowerRating)
(Meridia) needed closer scrutiny. Also, safety concerns were raised on Astrazeneca’s
(
AZN |
Quote |
Chart |
News |
PowerRating) Crestor and GlaxoSmithKline’s
(
GSK |
Quote |
Chart |
News |
PowerRating) Serevent.
Genentech
(
DNA |
Quote |
Chart |
News |
PowerRating) and OSI
Pharmaceuticals
(
OSIP |
Quote |
Chart |
News |
PowerRating) said that its lung cancer drug Tarceva received
FDA approval–in only 3.5 months. Price: $2000 for a 1-month supply.
Patients taking Tarceva lived, on average, 4 months longer. The drug is a competitor to Astrazeneca’s Iressa.
Trader talk: Â techs due for backing and filling
                  Â
indices remain near their highs  Â
                  Â
strong inflows into stock mutual funds  Â
                  Â
path of lest resistance is still up
                  Â
SOX near its 200-day moving average
This day in history:
1959Â Ford cancelled the Edsel
1965Â Pop Tarts
created
| Dow | -115.64 | 10456.91 |
| S&P 500 | -13.21 | 1170.34 |
| Nasdaq | -33.65 | 2070.63 |
Strong sectors were: Gold
(
XAU.X |
Quote |
Chart |
News |
PowerRating) +1.02%, Oil
Services
(
OSX.X |
Quote |
Chart |
News |
PowerRating) +1.81%, Natural Gas
(
XNG.X |
Quote |
Chart |
News |
PowerRating) +1.10%.
Weak sectors were: Airlines
(
XAL.X |
Quote |
Chart |
News |
PowerRating) -4.14%, Semis
(
SOX.X |
Quote |
Chart |
News |
PowerRating) -3.07%, Brokers
(
XDB.X |
Quote |
Chart |
News |
PowerRating)
-2.51%.
The dollar was -0.37 at 83.30
Gold was +4.10 to 446.60
Crude Oil was +2.42 at 48.80
ce=”Arial” size=”2″ face=”Arial”>Volume was 1.52 billion on the NYSE and
2 billion on the Nasdaq.
Market breadth was negative.
| NYSE | Issues | |
| Advancing | 940 | Up Vol 334 |
| Declining | 2400 | Down Vol 1048 |
| Ratio | 2.55 | 3.13 |
| Nasdaq |
||
| Advancing | 965 | Up Vol 604 |
| Declining | 2151 | Down Vol 1292 |
| Ratio | 2.22 | 2.13 |
Stocks in the News
Oracle
(
ORCL |
Quote |
Chart |
News |
PowerRating) will report tender
offer results for PeopleSoft after 1 am ET Saturday.
Sirius
(
SIRI |
Quote |
Chart |
News |
PowerRating) named former Viacom chief
Mel Karmazin, as CEO. Talk: will satellite radio kill broadcast radio?
Novell
(
NOVL |
Quote |
Chart |
News |
PowerRating) beat by a penny, and a
Q3 profit compared to a year earlier loss.
Marvel (MRVL)
beat by a penny; margins were in-line. UBS raised its 2005 revenue estimates but
lowered its earnings estimates.
Brice Wightman